首页 | 本学科首页   官方微博 | 高级检索  
     

含左旋氧氟沙星方案治疗耐多药肺结核疗效分析
引用本文:黄钥藩,杨仪,陈尊杰.含左旋氧氟沙星方案治疗耐多药肺结核疗效分析[J].临床荟萃,2004,19(12):663-665.
作者姓名:黄钥藩  杨仪  陈尊杰
作者单位:汕头市第三人民医院,呼吸内科,广东,汕头,515073
摘    要:目的 观察和评价含左氧氟沙星方案在耐多药肺结核 (MDR TB)治疗中的效果。方法 将 131例复治涂阳耐多药肺结核 (MDR TB)患者随机分为治疗组 6 6例和对照组 6 5例 ;治疗组化疗方案以左旋氧氟沙星为主 ,联合利福喷汀、帕司烟肼、丙硫异烟胺、吡嗪酰胺、阿米卡星 ;对照组用氧氟沙星 ,联合用药同治疗组 ;所有病例疗程均为 2 1个月。结果 共有 12 8例患者完成疗程 ,治疗组 6 4例 ,痰菌阴转率 81.3% ;对照组 6 4例 ,痰菌阴转率 4 6 .9% ,痰菌阴转率治疗组明显高于对照组 (P <0 .0 1) ;治疗组病灶显吸率 4 8.4 % ,空洞闭合率 6 3.0 % ,治疗组明显高于对照组 (P <0 .0 1)。结论 用含左氧氟沙星方案治疗涂阳耐多药肺结核 ,有助于痰菌阴转、病灶吸收和空洞闭合 ,值得推广应用

关 键 词:结核    耐多药  左氧氟沙星  治疗效果
文章编号:1004-583X(2004)12-0663-03

Clinical efficacy of a combination regimen with levofloxacin in treatment of multi-drug resistant pulmonary tuberculosis
Abstract:Objective To study the clinical efficacy of a combination therapy with levofloxacin and other second-drug anti-tuberculosis drug in the treatment of multi-drug resistant pulmonary tuberculosis(MDR-TB).Methods One hundred and thirty-one patients with MDR-TB were assigned to a study group(66 cases),treated with levofloxacin,rifapentine,dipasic,protionamide,pyrazinamide and amikacin;or a control group,treated with ofloxacin rifapentine,dipasic,protionamide,pyrazinamide and amikacin.The course of treatment was 21 months.Results Sixty-four csses in the study group and 64 cases in the control goup completed the treatment.The sputum-negative conversion rate in the study group( 81.3%) was significantly higher than that in the control goup( 46.9%)(P< 0.01).The radiographic improvement rate was 48.4% in the study group,significantly higher than that in the control group( 17.2%)(P< 0.01).The closure rate of the lung cavities in the study group( 63.0%) was higher than that in the control group( 20.0%)(P< 0.01).Conclusion The regimen including levofloxacin and other second anti-tuberculosis drugs was effective and safe for the patients with MDR-TB.
Keywords:tuberculosis  pulmonary  multidrug-resistant  levofloxacin  treatment outcome
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号